Page 173 - TD-3-4

Tumor Discovery Signet ring cell carcinoma of the urinary bladder

doi: 10.4322/acr.2021.264 J Med. 1976;60(2):273-278.
10. Ivanov A, Antonov P, Zapryanov M, Uchikov P, Belovezhdov V. doi: 10.1016/0002-9343(76)90437-x
Primary signet-ring cell adenocarcinoma of the 15. Ronen S, Kroft SH, Olteanu H, Hosking PR, Harrington AM.
bladder-A case report and review of literature. Urol Case Carcinocythemia: A rare entity becoming more common? A
Rep. 2022;42:102022. 3-year, single institution series of seven cases and literature
doi: 10.1016/j.eucr.2022.102022 review. Int J Lab Hematol. 2019;41(1):69-79.
11. Bagaporo Larrazabal R Jr., Cheng PVC, David-Wang A, doi: 10.1111/ijlh.12924
Requiso D. Signet-ring cell adenocarcinoma of unknown 16. Krawczyk P, Jassem J, Wojas-Krawczyk K, Krzakowski M,
primary presenting with superior vena cava (SVC) syndrome: Dziadziuszko R, Olszewski W. New genetic technologies
Rare type of cancer. BMJ Case Rep. 2019;12(12):e232269. in diagnosis and treatment of cancer of unknown primary.
doi: 10.1136/bcr-2019-232269 Cancers (Basel). 2022;14(14):3429.
12. Nicolazzo C, Raimondi C, Gradilone A, et al. Circulating doi: 10.3390/cancers14143429
tumor cells in right- and left-sided colorectal cancer. Cancers 17. Hayashi H, Takiguchi Y, Minami H, et al. Site-specific and
(Basel). 2019;11(8):1042. targeted therapy based on molecular profiling by next-
doi: 10.3390/cancers11081042 generation sequencing for cancer of unknown primary
site: A nonrandomized phase 2 clinical trial. JAMA Oncol.
13. DeMay RM, Grathwohl MA. Signet-ring-cell (colloid) 2020;6(12):1931-1938.
carcinoma of the urinary bladder. Cytologic, histologic
and ultrastructural findings in one case. Acta Cytol. doi: 10.1001/jamaoncol.2020.4643
1985;29(2):132-136. 18. Lu MY, Chen TY, Williamson DFK, et al. AI-based pathology
predicts origins for cancers of unknown primary. Nature.
14. Carey RW, Taft PD, Bennett JM, Kaufman S.
Carcinocythemia (carcinoma cell leukemia). An acute 2021;594(7861):106-110.
leukemia-like picture due to metastatic carcinoma cells. Am doi: 10.1038/s41586-021-03512-4

Volume 3 Issue 4 (2024) 5 doi: 10.36922/td.3736